{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:47:01Z","timestamp":1790786821476,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"binwu Sheng","award":["2020JM-395"],"award-info":[{"award-number":["2020JM-395"]}]},{"name":"binwu Sheng","award":["2020JM-395"],"award-info":[{"award-number":["2020JM-395"]}]},{"name":"binwu Sheng","award":["2020JM-395"],"award-info":[{"award-number":["2020JM-395"]}]},{"name":"binwu Sheng","award":["2020JM-395"],"award-info":[{"award-number":["2020JM-395"]}]},{"name":"binwu Sheng","award":["2020JM-395"],"award-info":[{"award-number":["2020JM-395"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gallbladder stone diseases (GSD) is a main risk factor of gallbladder cancer (GBC). This study aimed to reveal their bridge to metabolic syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material\/method<\/jats:title>\n                <jats:p>The clinical and experimental data of 2210 GBC patients, from 3524 Chinese patients, in our hospital from Jan. 2009 to Dec. 2020 were summarized. The metabolic syndrome indexes, influencing factors for both GBC and GSD, were analyzed by unconditional logistic regression in this case\u2013control study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>There were significantly higher morbidity of GBC in the overall, GSD and non-GSD with hypertriglyceridemia patients versus non-hypertriglyceridemia ones (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, all). In GSD patients, univariate regression showed a significantly positive correlation between serum triglyceride (TG), low density lipoprotein cholesterol (LDL-c), fasting insulin (FINS) levels, Homeostasis model assessment-insulin resistance (HOMA-IR), female being, body mass index, hypertriglyceridemia and hazard of GBC with GSD (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, all), and a significantly negative correlation to systolic pressure (SBP), diastolic pressure (DBP), hypertension and high-density lipoprotein cholesterol (HDL-c), fasting blood glucose (FBG) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05, all); multivariate regression showed that serum triglyceride was the most significantly positive factor associated to GBC (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, all) among the hazard factors including serum TG, LDL-c levels, HOMA-IR. In non-GSD ones, multivariate regression showed that HOMA-IR was the most significantly positive factor associated to GBC among the hazard factors including serum TG, LDL-c levels, HOMA-IR, female being, while DM had a significantly inversion negative association (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We found initially that elevated serum TG levels could be the most remarkable independent predicting factor for GBC risk with GSD, while insulin resistance might act as the first one in non-GSD. More importantly, we advocated initially the sharp rise of serum TG levels as the potential of a candidate diagnostic or prognostic biomarker of GBC with GSD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study may be performed in accordance with the ethical standards provided by the responsible committee of our institution (First Affiliated Hospital of Xi\u2019an Jiaotong University. XJTU1AF2020LSK-160) at which the work was carried out an in accordance with the Declaration of Helsinki. The ethics committee of our institution strictly comply with the requirements of ICH-GCP\u3001GCP and relevant regulations to construct, operate and implement operating procedures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-022-01189-y","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T06:02:36Z","timestamp":1667887356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Elevated serum triglyceride levels may be a key independent predicting factor for gallbladder cancer risk in gallbladder stone disease patients: a case\u2013control study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yong","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binwu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"issue":"2","key":"1189_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1479-666X(08)80073-X","volume":"6","author":"CH Lai","year":"2008","unstructured":"Lai CH, Lau WY. Gallbladder cancer\u2013a comprehensive review. Surgeon. 2008;6(2):101\u201310.","journal-title":"Surgeon"},{"key":"1189_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2017.07.046","volume":"45","author":"SH Kim","year":"2017","unstructured":"Kim SH, Jung D, Ahn JH, Kim KS. Differentiation between gallbladder cancer with acute cholecystitis: considerations for surgeons during emergency cholecystectomy, a cohort study. Int J Surg. 2017;45:1\u20137.","journal-title":"Int J Surg"},{"issue":"4","key":"1189_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/SGA.0000000000000235","volume":"39","author":"M Pak","year":"2016","unstructured":"Pak M, Lindseth G. Risk factors for cholelithiasis. Gastroenterol Nurs. 2016;39(4):297\u2013309.","journal-title":"Gastroenterol Nurs"},{"issue":"2","key":"1189_CR4","first-page":"245","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"Espinoza JA, Bizama C, Garcia P, Ferreccio C, Javle M, Miquel JF, et al. The inflammatory inception of gallbladder cancer. Biochim Biophys Acta. 2016;1865(2):245\u201354.","journal-title":"Biochim Biophys Acta"},{"issue":"2 Pt 2","key":"1189_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.gene.2015.10.004","volume":"576","author":"TD Singh","year":"2016","unstructured":"Singh TD, Gupta S, Shrivastav BR, Tiwari PK. Epigenetic profiling of gallbladder cancer and gall stone diseases: evaluation of role of tumour associated genes. Gene. 2016;576(2 Pt 2):743\u201352.","journal-title":"Gene"},{"issue":"1","key":"1189_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1586\/17474124.2016.1109445","volume":"10","author":"P Portincasa","year":"2016","unstructured":"Portincasa P, Di Ciaula A, de Bari O, Garruti G, Palmieri VO, Wang DQ. Management of gallstones and its related complications. Expert Rev Gastroenterol Hepatol. 2016;10(1):93\u2013112.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1189_CR7","doi-asserted-by":"crossref","unstructured":"Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res.\u00a02018;7(F1000 Faculty Rev):1529.","DOI":"10.12688\/f1000research.15505.1"},{"key":"1189_CR8","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","volume":"521","author":"J Huang","year":"2021","unstructured":"Huang J, Patel HK, Boakye D, Chandrasekar VT, Koulaouzidis A, Lucero-Prisno Iii DE, et al. Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis. Cancer Lett. 2021;521:238\u201351.","journal-title":"Cancer Lett"},{"issue":"2","key":"1189_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089368","volume":"9","author":"W Borena","year":"2014","unstructured":"Borena W, Edlinger M, Bjorge T, Haggstrom C, Lindkvist B, Nagel G, et al. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS ONE. 2014;9(2): e89368.","journal-title":"PLoS ONE"},{"issue":"48","key":"1189_CR10","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.3748\/wjg.v25.i48.6916","volume":"25","author":"CP Rice","year":"2019","unstructured":"Rice CP, Vaishnavi KB, Chao C, Jupiter D, Schaeffer AB, Jenson WR, et al. Operative complications and economic outcomes of cholecystectomy for acute cholecystitis. World J Gastroenterol. 2019;25(48):6916\u201327.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1189_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MOG.0000000000000419","volume":"34","author":"MP Lamberts","year":"2018","unstructured":"Lamberts MP. Indications of cholecystectomy in gallstone disease. Curr Opin Gastroenterol. 2018;34(2):97\u2013102.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"1189_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12944-020-01402-8","volume":"19","author":"B Sheng","year":"2020","unstructured":"Sheng B, Zhao Q, Ma M, Zhang J. An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study. Lipids Health Dis. 2020;19(1):228.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1189_CR13","first-page":"12","volume":"61","author":"Chinese Elderly Type 2 Diabetes P","year":"2022","unstructured":"Chinese Elderly Type 2 Diabetes P, Treatment of Clinical Guidelines Writing G, Geriatric E, Metabolism Branch of Chinese Geriatric S, Geriatric E, Metabolism Branch of Chinese Geriatric Health Care S, et al. Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition). Zhonghua Nei Ke Za Zhi. 2022;61(1):12\u201350.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"1189_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","volume":"79","author":"A Al-Makki","year":"2022","unstructured":"Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, et al. Hypertension pharmacological treatment in adults: a world health organization guideline executive summary. Hypertension. 2022;79(1):293\u2013301.","journal-title":"Hypertension"},{"issue":"2","key":"1189_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.26444\/aaem\/109225","volume":"27","author":"S Placzkowska","year":"2020","unstructured":"Placzkowska S, Pawlik-Sobecka L, Kokot I, Piwowar A. Estimation of reference intervals of insulin resistance (HOMA), insulin sensitivity (Matsuda), and insulin secretion sensitivity indices (ISSI-2) in polish young people. Ann Agric Environ Med. 2020;27(2):248\u201354.","journal-title":"Ann Agric Environ Med"},{"issue":"6","key":"1189_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/MOL.0000000000000710","volume":"31","author":"A Wolska","year":"2020","unstructured":"Wolska A, Yang ZH, Remaley AT. Hypertriglyceridemia: new approaches in management and treatment. Curr Opin Lipidol. 2020;31(6):331\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"6","key":"1189_CR17","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/hep.31585","volume":"73","author":"J Bragelmann","year":"2021","unstructured":"Bragelmann J, Barahona Ponce C, Marcelain K, Roessler S, Goeppert B, Gallegos I, et al. Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology. 2021;73(6):2293\u2013310.","journal-title":"Hepatology"},{"issue":"2","key":"1189_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172\u201387.","journal-title":"Gut Liver"},{"issue":"10","key":"1189_CR19","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1002\/ijc.23307","volume":"122","author":"G Andreotti","year":"2008","unstructured":"Andreotti G, Chen J, Gao YT, Rashid A, Chang SC, Shen MC, et al. Serum lipid levels and the risk of biliary tract cancers and biliary stones: a population-based study in China. Int J Cancer. 2008;122(10):2322\u20139.","journal-title":"Int J Cancer"},{"issue":"7","key":"1189_CR20","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00535-012-0683-z","volume":"48","author":"HC Lai","year":"2013","unstructured":"Lai HC, Chang SN, Lin CC, Chen CC, Chou JW, Peng CY, et al. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study. J Gastroenterol. 2013;48(7):856\u201365.","journal-title":"J Gastroenterol"},{"issue":"2","key":"1189_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/13813450902878054","volume":"115","author":"S Becker","year":"2009","unstructured":"Becker S, Dossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem. 2009;115(2):86\u201396.","journal-title":"Arch Physiol Biochem"},{"issue":"3","key":"1189_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12(3):159\u201369.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1189_CR23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/cas.12463","volume":"105","author":"H Zhou","year":"2014","unstructured":"Zhou H, Guo W, Zhao Y, Wang Y, Zha R, Ding J, et al. MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer. Cancer Sci. 2014;105(8):956\u201365.","journal-title":"Cancer Sci"},{"issue":"21\u201322","key":"1189_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.cca.2010.08.003","volume":"411","author":"AH Smelt","year":"2010","unstructured":"Smelt AH. Triglycerides and gallstone formation. Clin Chim Acta. 2010;411(21\u201322):1625\u201331.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1189_CR25","first-page":"43","volume":"88","author":"RA Ivanchenkova","year":"2010","unstructured":"Ivanchenkova RA, Gatsenko VP, At\u2019kova ER, Meshkov AN. Disorders of lipid metabolism in patients with cholelithiasis and gallbladder cholesterosis depending on apolipoprotein E genotype. Klin Med (Mosk). 2010;88(4):43\u20138.","journal-title":"Klin Med (Mosk)"},{"issue":"10","key":"1189_CR26","first-page":"46","volume":"82","author":"RA Ivanchenkova","year":"2004","unstructured":"Ivanchenkova RA, Sharashkina NV. Heterogeneity of low-density lipoproteins in cholesterolosis of the gallbladder and cholelithiasis. Klin Med (Mosk). 2004;82(10):46\u20139.","journal-title":"Klin Med (Mosk)"},{"issue":"5","key":"1189_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5009\/gnl15600","volume":"10","author":"KS Yoo","year":"2016","unstructured":"Yoo KS, Choi HS, Jun DW, Lee HL, Lee OY, Yoon BC, et al. MUC expression in gallbladder epithelial tissues in cholesterol-associated gallbladder disease. Gut Liver. 2016;10(5):851\u20138.","journal-title":"Gut Liver"},{"issue":"8","key":"1189_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/jso.20528","volume":"93","author":"I Roa","year":"2006","unstructured":"Roa I, Ibacache G, Roa J, Araya J, de Aretxabala X, Munoz S. Gallstones and gallbladder cancer-volume and weight of gallstones are associated with gallbladder cancer: a case-control study. J Surg Oncol. 2006;93(8):624\u20138.","journal-title":"J Surg Oncol"},{"issue":"3","key":"1189_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3122\/jabfm.19.3.310","volume":"19","author":"RN Pejic","year":"2006","unstructured":"Pejic RN, Lee DT. Hypertriglyceridemia. J Am Board Fam Med. 2006;19(3):310\u20136.","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"1189_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/sj.pcan.4500834","volume":"8","author":"L Wuermli","year":"2005","unstructured":"Wuermli L, Joerger M, Henz S, Schmid HP, Riesen WF, Thomas G, et al. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis. 2005;8(4):316\u201320.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"1189_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","volume":"65","author":"A Asgharpour","year":"2016","unstructured":"Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, et al. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol. 2016;65(3):579\u201388.","journal-title":"J Hepatol"},{"issue":"11","key":"1189_CR32","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/jjco\/hyt125","volume":"43","author":"A Hirasawa","year":"2013","unstructured":"Hirasawa A, Makita K, Akahane T, Yokota M, Yamagami W, Banno K, et al. Hypertriglyceridemia is frequent in endometrial cancer survivors. Jpn J Clin Oncol. 2013;43(11):1087\u201392.","journal-title":"Jpn J Clin Oncol"},{"issue":"33","key":"1189_CR33","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.3748\/wjg.v22.i33.7463","volume":"22","author":"HY Feng","year":"2016","unstructured":"Feng HY, Chen YC. Role of bile acids in carcinogenesis of pancreatic cancer: an old topic with new perspective. World J Gastroenterol. 2016;22(33):7463\u201377.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1:s3-405","key":"1189_CR34","doi-asserted-by":"publisher","first-page":"s87","DOI":"10.5604\/01.3001.0010.5501","volume":"16","author":"A Di Ciaula","year":"2017","unstructured":"Di Ciaula A, Wang DQ, Molina-Molina E, Lunardi Baccetto R, Calamita G, Palmieri VO, et al. Bile acids and cancer: direct and environmental-dependent effects. Ann Hepatol. 2017;16(Suppl 1:s3-405):s87\u2013105.","journal-title":"Ann Hepatol"},{"key":"1189_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335.","journal-title":"Metabolism"},{"key":"1189_CR36","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.2741\/4070","volume":"17","author":"F Wang","year":"2012","unstructured":"Wang F, Wang B, Qiao L. Association between obesity and gallbladder cancer. Front Biosci (Landmark Ed). 2012;17:2550\u20138.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1189_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","volume":"960","author":"D Yazici","year":"2017","unstructured":"Yazici D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol. 2017;960:277\u2013304.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"1189_CR38","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/bjc.2011.363","volume":"105","author":"FM Shebl","year":"2011","unstructured":"Shebl FM, Andreotti G, Meyer TE, Gao YT, Rashid A, Yu K, et al. Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai. China Br J Cancer. 2011;105(9):1424\u20139.","journal-title":"China Br J Cancer"},{"key":"1189_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/nyas.12416","volume":"1311","author":"NA Berger","year":"2014","unstructured":"Berger NA. Obesity and cancer pathogenesis. Ann N Y Acad Sci. 2014;1311:57\u201376.","journal-title":"Ann N Y Acad Sci"},{"key":"1189_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mrfmmm.2013.03.006","volume":"745\u2013746","author":"EM Othman","year":"2013","unstructured":"Othman EM, Leyh A, Stopper H. Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. Mutat Res. 2013;745\u2013746:34\u20139.","journal-title":"Mutat Res"},{"issue":"2","key":"1189_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/SLA.0000000000001938","volume":"266","author":"WY Chey","year":"2017","unstructured":"Chey WY, Frankel WL, Roy S, Datta S, Sen CK, Dillhoff M, et al. Primary pancreatic Secretinoma: further evidence supporting secretin as a Diarrheogenic hormone. Ann Surg. 2017;266(2):346\u201352.","journal-title":"Ann Surg"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01189-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01189-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T18:04:35Z","timestamp":1667930675000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01189-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01189-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"15 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the First Affiliated Hospital of Xi\u2019an Jiaotong University. XJTU1AF2020LSK-160. All participants provided written informed consent before being admitted to the First Affiliated Hospital of our University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in the retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}